Differential expression of activator protein-2 isoforms in renal cell carcinoma

Mototsugu Oya, Shuji Mikami, Ryuichi Mizuno, Akira Miyajima, Yutaka Horiguchi, Jun Nakashima, Ken Marumo, Makio Mukai, Masaru Murai

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objectives To investigate the expression of activator protein-2 (AP-2) in renal cell carcinoma (RCC) by immunohistochemistry. Three AP-2 isoforms alpha (α), beta (β), and gamma (γ) are known to exhibit a highly homologous structure; however, their functions are considered to be different. AP-2 has been implicated to play a role in carcinogenesis, as well as in the development of the kidney. Methods The expression of the three AP-2 isoforms, α, β, and γ, was determined in 58 patients with RCC by immunohistochemistry. Epidermal growth factor receptor and erbB2 expression in 42 patients with RCC was also evaluated to investigate the correlation with AP-2 isoforms. Results AP-2 isoforms are differentially expressed in normal renal tubules. Of 58 RCC tissue specimens, 15 (25.9%) demonstrated nuclear and cytoplasmic expression of AP-2α. Clear cell RCC had a significantly greater rate of AP-2α expression than the nonclear subtypes (14 of 41 clear versus 1 of 17 nonclear subtypes). Of the 58 specimens, 8 (13.8%) showed nuclear staining for AP-2β; notably, localized small cases had a significantly greater rate of nuclear staining for AP-2β (5 of 13 in pT1a versus 3 of 45 in pT1b or greater). In addition, only 2 cases (3.5%) demonstrated nuclear staining for AP-2γ. Epidermal growth factor receptor and erbB2 expression did not correlate with expression of the AP-2 isoforms. Conclusions AP-2 isoforms were differentially expressed in RCC, as well as in the adult normal kidney. AP-2α was dominantly expressed in clear cell RCC. AP-2β expression was observed in the low-stage subtypes of RCC, and this transcription factor may be related to early carcinogenesis.

Original languageEnglish
Pages (from-to)162-167
Number of pages6
JournalUrology
Volume64
Issue number1
DOIs
Publication statusPublished - 2004 Jul

Fingerprint

Renal Cell Carcinoma
Protein Isoforms
Proteins
Staining and Labeling
Kidney
Epidermal Growth Factor Receptor
Carcinogenesis
Immunohistochemistry
Transcription Factors

ASJC Scopus subject areas

  • Urology

Cite this

Differential expression of activator protein-2 isoforms in renal cell carcinoma. / Oya, Mototsugu; Mikami, Shuji; Mizuno, Ryuichi; Miyajima, Akira; Horiguchi, Yutaka; Nakashima, Jun; Marumo, Ken; Mukai, Makio; Murai, Masaru.

In: Urology, Vol. 64, No. 1, 07.2004, p. 162-167.

Research output: Contribution to journalArticle

Oya, M, Mikami, S, Mizuno, R, Miyajima, A, Horiguchi, Y, Nakashima, J, Marumo, K, Mukai, M & Murai, M 2004, 'Differential expression of activator protein-2 isoforms in renal cell carcinoma', Urology, vol. 64, no. 1, pp. 162-167. https://doi.org/10.1016/j.urology.2004.02.022
Oya, Mototsugu ; Mikami, Shuji ; Mizuno, Ryuichi ; Miyajima, Akira ; Horiguchi, Yutaka ; Nakashima, Jun ; Marumo, Ken ; Mukai, Makio ; Murai, Masaru. / Differential expression of activator protein-2 isoforms in renal cell carcinoma. In: Urology. 2004 ; Vol. 64, No. 1. pp. 162-167.
@article{2b2f678889be4fadb2cca6b6fa52092a,
title = "Differential expression of activator protein-2 isoforms in renal cell carcinoma",
abstract = "Objectives To investigate the expression of activator protein-2 (AP-2) in renal cell carcinoma (RCC) by immunohistochemistry. Three AP-2 isoforms alpha (α), beta (β), and gamma (γ) are known to exhibit a highly homologous structure; however, their functions are considered to be different. AP-2 has been implicated to play a role in carcinogenesis, as well as in the development of the kidney. Methods The expression of the three AP-2 isoforms, α, β, and γ, was determined in 58 patients with RCC by immunohistochemistry. Epidermal growth factor receptor and erbB2 expression in 42 patients with RCC was also evaluated to investigate the correlation with AP-2 isoforms. Results AP-2 isoforms are differentially expressed in normal renal tubules. Of 58 RCC tissue specimens, 15 (25.9{\%}) demonstrated nuclear and cytoplasmic expression of AP-2α. Clear cell RCC had a significantly greater rate of AP-2α expression than the nonclear subtypes (14 of 41 clear versus 1 of 17 nonclear subtypes). Of the 58 specimens, 8 (13.8{\%}) showed nuclear staining for AP-2β; notably, localized small cases had a significantly greater rate of nuclear staining for AP-2β (5 of 13 in pT1a versus 3 of 45 in pT1b or greater). In addition, only 2 cases (3.5{\%}) demonstrated nuclear staining for AP-2γ. Epidermal growth factor receptor and erbB2 expression did not correlate with expression of the AP-2 isoforms. Conclusions AP-2 isoforms were differentially expressed in RCC, as well as in the adult normal kidney. AP-2α was dominantly expressed in clear cell RCC. AP-2β expression was observed in the low-stage subtypes of RCC, and this transcription factor may be related to early carcinogenesis.",
author = "Mototsugu Oya and Shuji Mikami and Ryuichi Mizuno and Akira Miyajima and Yutaka Horiguchi and Jun Nakashima and Ken Marumo and Makio Mukai and Masaru Murai",
year = "2004",
month = "7",
doi = "10.1016/j.urology.2004.02.022",
language = "English",
volume = "64",
pages = "162--167",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Differential expression of activator protein-2 isoforms in renal cell carcinoma

AU - Oya, Mototsugu

AU - Mikami, Shuji

AU - Mizuno, Ryuichi

AU - Miyajima, Akira

AU - Horiguchi, Yutaka

AU - Nakashima, Jun

AU - Marumo, Ken

AU - Mukai, Makio

AU - Murai, Masaru

PY - 2004/7

Y1 - 2004/7

N2 - Objectives To investigate the expression of activator protein-2 (AP-2) in renal cell carcinoma (RCC) by immunohistochemistry. Three AP-2 isoforms alpha (α), beta (β), and gamma (γ) are known to exhibit a highly homologous structure; however, their functions are considered to be different. AP-2 has been implicated to play a role in carcinogenesis, as well as in the development of the kidney. Methods The expression of the three AP-2 isoforms, α, β, and γ, was determined in 58 patients with RCC by immunohistochemistry. Epidermal growth factor receptor and erbB2 expression in 42 patients with RCC was also evaluated to investigate the correlation with AP-2 isoforms. Results AP-2 isoforms are differentially expressed in normal renal tubules. Of 58 RCC tissue specimens, 15 (25.9%) demonstrated nuclear and cytoplasmic expression of AP-2α. Clear cell RCC had a significantly greater rate of AP-2α expression than the nonclear subtypes (14 of 41 clear versus 1 of 17 nonclear subtypes). Of the 58 specimens, 8 (13.8%) showed nuclear staining for AP-2β; notably, localized small cases had a significantly greater rate of nuclear staining for AP-2β (5 of 13 in pT1a versus 3 of 45 in pT1b or greater). In addition, only 2 cases (3.5%) demonstrated nuclear staining for AP-2γ. Epidermal growth factor receptor and erbB2 expression did not correlate with expression of the AP-2 isoforms. Conclusions AP-2 isoforms were differentially expressed in RCC, as well as in the adult normal kidney. AP-2α was dominantly expressed in clear cell RCC. AP-2β expression was observed in the low-stage subtypes of RCC, and this transcription factor may be related to early carcinogenesis.

AB - Objectives To investigate the expression of activator protein-2 (AP-2) in renal cell carcinoma (RCC) by immunohistochemistry. Three AP-2 isoforms alpha (α), beta (β), and gamma (γ) are known to exhibit a highly homologous structure; however, their functions are considered to be different. AP-2 has been implicated to play a role in carcinogenesis, as well as in the development of the kidney. Methods The expression of the three AP-2 isoforms, α, β, and γ, was determined in 58 patients with RCC by immunohistochemistry. Epidermal growth factor receptor and erbB2 expression in 42 patients with RCC was also evaluated to investigate the correlation with AP-2 isoforms. Results AP-2 isoforms are differentially expressed in normal renal tubules. Of 58 RCC tissue specimens, 15 (25.9%) demonstrated nuclear and cytoplasmic expression of AP-2α. Clear cell RCC had a significantly greater rate of AP-2α expression than the nonclear subtypes (14 of 41 clear versus 1 of 17 nonclear subtypes). Of the 58 specimens, 8 (13.8%) showed nuclear staining for AP-2β; notably, localized small cases had a significantly greater rate of nuclear staining for AP-2β (5 of 13 in pT1a versus 3 of 45 in pT1b or greater). In addition, only 2 cases (3.5%) demonstrated nuclear staining for AP-2γ. Epidermal growth factor receptor and erbB2 expression did not correlate with expression of the AP-2 isoforms. Conclusions AP-2 isoforms were differentially expressed in RCC, as well as in the adult normal kidney. AP-2α was dominantly expressed in clear cell RCC. AP-2β expression was observed in the low-stage subtypes of RCC, and this transcription factor may be related to early carcinogenesis.

UR - http://www.scopus.com/inward/record.url?scp=3042696396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042696396&partnerID=8YFLogxK

U2 - 10.1016/j.urology.2004.02.022

DO - 10.1016/j.urology.2004.02.022

M3 - Article

C2 - 15245963

AN - SCOPUS:3042696396

VL - 64

SP - 162

EP - 167

JO - Urology

JF - Urology

SN - 0090-4295

IS - 1

ER -